Should Patients Be Evaluated for ADHD While Using ADHD Medication?

被引:0
|
作者
Lovett, Benjamin J. [1 ,5 ]
Nelson, Jason M. [2 ]
Jordan, Alexander H. [3 ,4 ]
机构
[1] Columbia Univ, Teachers Coll, Sch Psychol Program, New York, NY USA
[2] Univ Georgia, Regents Ctr Learning Disorders, Athens, GA USA
[3] McLean Hosp, Belmont, MA USA
[4] Harvard Med Sch, Dept Psychiat, Cambridge, MA USA
[5] Columbia Univ, Teachers Coll, Sch Psychol Program, Box 120,525 West 120th St, New York, NY 10027 USA
关键词
attention-deficit/hyperactivity disorder; diagnostic assessment; stimulant medication; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; OF-THE-LITERATURE; STIMULANT MEDICATION; EXTENDED-RELEASE; HYPERACTIVITY; METHYLPHENIDATE; CHILDREN; EFFICACY; WITHDRAWAL; PSYCHOSTIMULANTS;
D O I
10.1037/pro0000555
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Psychologists often perform evaluations on patients who are already being prescribed stimulant medication for attention-deficit/hyperactivity disorder. The evaluation may be sought to confirm the diagnosis or to determine specific treatment or accommodation needs. In these cases, psychologists are often asked whether the patient should take their medication as prescribed on the day of the evaluation. There does not appear to be any existing authoritative guidance on this question, and different clinics and clinicians have different policies. In the present article, relevant research on stimulant effects and attention-deficit/hyperactivity disorder assessment tools is reviewed, to develop empirically informed guidance for determining when patients should take their medication on evaluation day and when they should not. The article concludes with several proposed guidelines for practice, synthesizing findings from the available research with consideration of psychologists' ethical responsibilities.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 50 条
  • [31] Risk of Bias and Quality of Evidence for Treatment of ADHD With Stimulant Medication
    Swanson, James M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (04) : 638 - 643
  • [32] Parent Medication Concerns Predict Underutilization of Mental Health Services for Minority Children With ADHD
    Berger-Jenkins, Evelyn
    McKay, Mary
    Newcorn, Jeffrey
    Bannon, William
    Laraque, Danielle
    CLINICAL PEDIATRICS, 2012, 51 (01) : 65 - 76
  • [33] ADHD Medication in the Longer Term
    Taylor, Eric
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2019, 47 (06): : 542 - 546
  • [34] Stimulant Medication for ADHD in Opioid Maintenance Treatment
    Abel, Kristine Fiksdal
    Bramness, Jorgen G.
    Martinsen, Egil W.
    JOURNAL OF DUAL DIAGNOSIS, 2014, 10 (01) : 32 - 38
  • [35] Stimulant ADHD medication and risk for substance abuse
    Chang, Zheng
    Lichtenstein, Paul
    Halldner, Linda
    D'Onofrio, Brian
    Serlachius, Eva
    Fazel, Seena
    Langstrom, Niklas
    Larsson, Henrik
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2014, 55 (08) : 878 - 885
  • [36] Emotional dysregulation and stimulant medication in adult ADHD
    Greenfield, Myrto Sklivanioti
    Wang, Yanlu
    Hamilton, J. Paul
    Thunberg, Per
    Msghina, Mussie
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2024, 49 (04): : E242 - E251
  • [37] Prevalence, diagnosis and medication of hyperactivity/ADHD in France
    Ponnou, Sebastien
    ANNALES MEDICO-PSYCHOLOGIQUES, 2022, 180 (10): : 995 - 999
  • [38] Racial Differences in Medication Use in a National Sample of Children with ADHD Enrolled in Special Education
    Graves, Scott L., Jr.
    Serpell, Zewelanji
    SCHOOL MENTAL HEALTH, 2013, 5 (04) : 175 - 182
  • [39] Use of psychostimulant medication for ADHD in South Australia
    Reid, R
    Hakendorf, P
    Prosser, B
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (08) : 906 - 913
  • [40] Review of Medication Adherence in Children and Adults with ADHD
    Adler, Lisa D.
    Nierenberg, Andrew A.
    POSTGRADUATE MEDICINE, 2010, 122 (01) : 184 - 191